1474. Impact of 13-valent Pneumococcal Conjugate Vaccine (PCV13) on Non-bacteremic Pneumococcal Pneumonia (NBPP) among Adults in the United States, 2013-2017

Gelijkaardige items

• Direct and Indirect Impact of 13-valent Pneumococcal Conjugate Vaccine (PCV13) on Invasive Pneumococcal Disease (IPD) Among Children and Adults in the U.S.
  door: Pilishvili, Tamara, et al.
  Gepubliceerd in: (2017)
• Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices
  door: Matanock, Almea, et al.
  Gepubliceerd in: (2019)
• 1470. Epidemiology of Invasive Pneumococcal Disease (IPD) Following 18 years of Pneumococcal Conjugate Vaccine (PCV) Use in the United States
  door: Pilishvili, Tamara, et al.
  Gepubliceerd in: (2020)
• 1461. Non-Invasive Pneumococcal Pneumonia in the United States, 2013–2014
  door: Matanock, Almea, et al.
  Gepubliceerd in: (2018)
• Changes in invasive pneumococcal disease among adults living with HIV following introduction of 13-valent pneumococcal conjugate vaccine, 2008–2014
  door: Kobayashi, Miwako, et al.
  Gepubliceerd in: (2017)